Pharma AG Novartis insider trades: Alnylam Pharmaceuticals (ALNY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pharma reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 20, 2012 | ALNY | ↓ Sell | 1,551,896 | $19.42 | $30.1M | Indirect | Sep 24, 2012 (4d) |
| Feb 23, 2012 | IDIX | ↑ Buy | 84,893 | $3.43 | $291K | Indirect | Feb 23, 2012 (0d) |
| Nov 22, 2011 | IDIX | ↑ Buy | 50,530 | $4.08 | $206K | Indirect | Nov 22, 2011 (0d) |
| Apr 13, 2011 | IDIX | ↑ Buy | 1,785,714 | $2.80 | $5.0M | Indirect | Apr 13, 2011 (0d) |
| Feb 25, 2011 | IDIX | ↑ Buy | 20,993 | $2.64 | $55K | Indirect | Feb 25, 2011 (0d) |
| Nov 26, 2010 | IDIX | ↑ Buy | 17,083 | $2.73 | $47K | Indirect | Nov 26, 2010 (0d) |
| Aug 23, 2010 | IDIX | ↑ Buy | 37,214 | $2.45 | $91K | Indirect | Aug 23, 2010 (0d) |
| Jun 8, 2010 | IDIX | ↑ Buy | 1,351 | $2.41 | $3K | Indirect | Jun 8, 2010 (0d) |
| Apr 23, 2010 | ALNY | ↑ Buy | 55,223 | $17.99 | $993K | Indirect | Apr 26, 2010 (3d) |
| Feb 26, 2010 | IDIX | ↑ Buy | 1,872 | $2.41 | $5K | Indirect | Feb 26, 2010 (0d) |
| Aug 21, 2009 | IDIX | ↑ Buy | 3,431 | $2.41 | $8K | Indirect | Aug 24, 2009 (3d) |
| May 29, 2009 | IDIX | ↑ Buy | 2,451 | $2.62 | $6K | Indirect | May 29, 2009 (0d) |
| May 6, 2009 | ALNY | ↑ Buy | 65,922 | $17.50 | $1.2M | Indirect | May 6, 2009 (0d) |
| Feb 23, 2009 | IDIX | ↑ Buy | 5,444 | $2.41 | $13K | Indirect | Feb 23, 2009 (0d) |
| Nov 19, 2008 | IDIX | ↑ Buy | 4,747 | $4.05 | $19K | Indirect | Nov 25, 2008 (6d) |
| Sep 2, 2008 | IDIX | ↑ Buy | 4,654 | $2.93 | $14K | Indirect | Sep 3, 2008 (1d) |
| May 29, 2008 | IDIX | ↑ Buy | 924 | $2.41 | $2K | Indirect | May 30, 2008 (1d) |
| May 8, 2008 | ALNY | ↑ Buy | 213,888 | $25.29 | $5.4M | See Note | May 14, 2008 (6d) |
| Jun 6, 2006 | IDIX | ↑ Buy | 365 | $20.48 | $7K | Indirect | Jun 8, 2006 (2d) |
| Apr 4, 2006 | IDIX | ↑ Buy | 2,938 | $16.23 | $48K | Indirect | Apr 6, 2006 (2d) |
| Nov 8, 2005 | REGN | ↓ Sell | 7,527,050 | $11.06 | $83.2M | Direct | Nov 10, 2005 (2d) |
| Oct 31, 2005 | IDIX | ↑ Buy | 3,939,131 | $20.61 | $81.2M | Indirect | Nov 2, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALNY insiders
Open-market trades in the last 12 months
About Pharma AG Novartis's insider trades
Pharma AG Novartis is a 10% owner of Alnylam Pharmaceuticals (ALNY). Since Oct 31, 2005, Pharma has reported 20 open-market purchases worth $94.6M and 2 sales worth $113.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include conversions (1 filing), other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALNY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.